Financhill
Back

Matinas BioPharma Holdings, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
29

MTNB
Matinas BioPharma Holdings, Inc.

Last Price:
$0.59
Seasonality Move:
-7.53%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MTNB is experiencing buying pressure, which is a positive indicator for future bullish movement.

Matinas BioPharma Holdings, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 0.61 Sell
20-day SMA: 0.61 Sell
50-day SMA: 0.65 Sell
200-day SMA: 1.1 Sell
8-day EMA: 0.61 Sell
20-day EMA: 0.62 Sell
50-day EMA: 0.7 Sell
200-day EMA: 1.2 Sell

Matinas BioPharma Holdings, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 45.91 Sell
Chaikin Money Flow: 13640 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.59 - 0.67) Sell
Bollinger Bands (100): (0.54 - 1.36) Sell

Matinas BioPharma Holdings, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Matinas BioPharma Holdings, Inc. Stock

Is Matinas BioPharma Holdings, Inc. Stock a Buy?

MTNB Technical Analysis vs Fundamental Analysis

Sell
29
Matinas BioPharma Holdings, Inc. (MTNB) is a Sell

Is Matinas BioPharma Holdings, Inc. a Buy or a Sell?

Matinas BioPharma Holdings, Inc. Stock Info

Market Cap:
3.9M
Price in USD:
0.61
Share Volume:
15.2K

Matinas BioPharma Holdings, Inc. 52-Week Range

52-Week High:
3.09
52-Week Low:
0.47
Sell
29
Matinas BioPharma Holdings, Inc. (MTNB) is a Sell

Matinas BioPharma Holdings, Inc. Share Price Forecast

Is Matinas BioPharma Holdings, Inc. Stock a Buy?

Fundamental Analysis of Matinas BioPharma Holdings, Inc.

Is Matinas BioPharma Holdings, Inc. a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.50 per share, and a decrease next year of $0.00 per share.

Technical Analysis of Matinas BioPharma Holdings, Inc.

Should I short Matinas BioPharma Holdings, Inc. stock?

* Matinas BioPharma Holdings, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.